Transgender women in the intervention condition will attend TransAction individual risk reduction sessions; skill building and open group support sessions, and social events between baseline and 3-month assessment. Transgender women participants in the control condition will be invited to social events only.
80 transgender women will be randomized to either an intervention condition (receiving all TransAction activities) or a control condition (being invited to TransAction social events only). We will evaluate outcomes such as advancement along the HIV prevention/care continua, sexual risks, substance use, self-efficacy in services seeking, social support, stigma, general well-being, and quality of life at baseline, 3-month, and 6-month follow-ups. Furthermore, we will assess implementation outcomes such as fidelity, adaptation, feasibility, acceptability, and sustainability through implementation documentation, investigator evaluation, and survey/focus groups with peer facilitators and TW participants.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
80
Immediately following the baseline, participants in the intervention condition will be invited to participate in the individual and group sessions, with topics around reducing HIV risk behaviors, regular HIV/CD4/viral load testing, ART/PrEP uptake and adherence, and family/social support, all to be completed within three months. All participants, including those in both intervention and control conditions, will be invited to two social events to disseminate health information, HIV prevention messages, and foster social support in a festive, party-style atmosphere.
University of Medicine and Pharmacy
Ho Chi Minh City, Vietnam
RECRUITINGPlacement on HIV prevention/care continua
An ordinal outcome from 1) HIV+; not taking ART; 2) HIV+; taking ART but not virally suppressed (including no viral load test in the last 6 months); 3) HIV+; taking ART and virtually suppressed; 4) HIV-, not having regular HIV testing; 5) HIV-, having regular HIV testing but not taking PrEP; and 6) HIV-; currently on PrEP. A higher value indicates better placement in HIV prevention/care continua.
Time frame: Baseline, 3-, and 6-months
Self-efficacy
Self-efficacy in seeking healthcare and social services, as well as self-efficacy in negotiating condom use.
Time frame: Baseline, 3-, and 6-months
Social support
Perceived support from family members, peers, service providers, and online resources
Time frame: Baseline, 3-, and 6-months
General wellbeing and quality of life
General wellbing and quality of life will be measured using Short Form-12 and Hospital Anxiety and Depression Scale
Time frame: Baseline, 3-, and 6-months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.